Julie A. O’Brien

2.0k citations

30 papers · 1.3k indexed · h-index 16

Cellular and Molecular Neuroscience top 2%
Molecular Biology top 10%
Cognitive Neuroscience top 10%
Organic Chemistry
Materials Chemistry

Co-authors: David L. Williams P. Jeffrey Conn Cyrille Sur Marlene A. Jacobson Wei Lemaire Craig W. Lindsley Douglas J. Pettibone Gene G. Kinney
Topics: Neuroscience and Neuropharmacology Research (16 papers)Receptor Mechanisms and Signaling (14 papers)Amino Acid Enzymes and Metabolism (3 papers)
Cited by: Cellular and Molecular Neuroscience Biological Psychiatry Toxicology
Journals: Proceedings of the National Academy of Sciences Annals of the New York Academy of Sciences Journal of Medicinal Chemistry
Partner nations: United States United Kingdom Poland

In The Last Decade

Julie A. O’Brien

30 papers receiving 1.3k citations

Peers

Countries citing papers authored by Julie A. O’Brien

Since Specialization

Citations

This map shows the geographic impact of Julie A. O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie A. O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie A. O’Brien more than expected).

Fields of papers citing papers by Julie A. O’Brien

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie A. O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie A. O’Brien. The network helps show where Julie A. O’Brien may publish in the future.

Co-authorship network of co-authors of Julie A. O’Brien

This figure shows the co-authorship network connecting the top 25 collaborators of Julie A. O’Brien. A scholar is included among the top collaborators of Julie A. O’Brien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie A. O’Brien. Julie A. O’Brien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of 4-arylquinoline-2-carboxamides, highly potent and selective class of mGluR2 negative allosteric modulators: From HTS to activity in animal models 2020 ·Bioorganic & Medicinal Chemistry Letters ·Youheng Shu,Tracy L. Diamond,James C. Hershey,(unknown),Brian C. Magliaro,Julie A. O’Brien,(unknown),(unknown),Victor N. Uebele,Jason M. Uslaner,(unknown),Antonella Converso	4
2	Identification of MK-8133: An orexin-2 selective receptor antagonist with favorable development properties 2015 ·Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk,(unknown),(unknown),Joseph G. Bruno,Mark H. Pausch,Julie A. O’Brien,Tamara D. Cabalu,Joanne Stevens,(unknown),Pamela L. Tannenbaum,Susan L. Garson,Alan T. Savitz,C. Meacham Harrell,Anthony L. Gotter,Christopher J. Winrow,John J. Renger,Paul J. Coleman	15
3	Breast-Conserving Surgery in Bilateral Breast Cancer 2015 ·Annals of Surgical Oncology ·Julie A. O’Brien,Alice Y. Ho,(unknown),Michelle Stempel,Sujata Patil,Kate Krause,Monica Morrow,Mary L. Gemignani	19
4	Synthesis and evaluation of carbon-linked analogs of dual orexin receptor antagonist filorexant 2014 ·Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk,(unknown),Christina N. Di Marco,Joseph G. Bruno,(unknown),Julie A. O’Brien,Tamara D. Cabalu,Joanne Stevens,(unknown),Pamela L. Tannenbaum,Anthony L. Gotter,Christopher J. Winrow,John J. Renger,Paul J. Coleman	7
5	Fleur-de-lis Panniculectomy After Bariatric Surgery 2011 ·Annals of Plastic Surgery ·Julie A. O’Brien,(unknown),(unknown),(unknown),(unknown),Raymond M. Dunn,Mustafa Akyürek,Janice F. Lalikos	8
6	The M1 Muscarinic Receptor Allosteric Agonists AC-42 and 1-[1′-(2-Methylbenzyl)-1,4′-bipiperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one Bind to a Unique Site Distinct from the Acetylcholine Orthosteric Site 2010 ·Molecular Pharmacology ·Marlene A. Jacobson,Constantine Kreatsoulas,Danette Pascarella,Julie A. O’Brien,Cyrille Sur	24
7	3-Aryl-5-phenoxymethyl-1,3-oxazolidin-2-ones as positive allosteric modulators of mGluR2 for the treatment of schizophrenia: Hit-to-lead efforts 2010 ·Bioorganic & Medicinal Chemistry Letters ·Edward J. Brnardic,Mark E. Fraley,R. M. Garbaccio,M. E. Layton,John M. Sanders,Chris Culberson,Marlene A. Jacobson,Brian C. Magliaro,Pete H. Hutson,Julie A. O’Brien,Sarah L. Huszar,Jason M. Uslaner,Kerry L. Fillgrove,Cuyue Tang,Yuhsin Kuo,(unknown),George D. Hartman	30
8	Differential effects of the mGluR5 positive allosteric modulator CDPPB in the cortex and striatum following repeated administration 2010 ·Neuropharmacology ·Sophie Parmentier‐Batteur,Julie A. O’Brien,Scott M. Doran,(unknown),Rosemarie B. Flick,Jason M. Uslaner,Hank Chen,(unknown),Theresa M. Williams,Marlene A. Jacobson,Pete H. Hutson	50
9	Discovery of N-{[1-(propylsulfonyl)-4-pyridin-2-ylpiperidin-4-yl]methyl}benzamides as novel, selective and potent GlyT1 inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Zhijian Zhao,William Leister,Julie A. O’Brien,Wei Lemaire,David L. Williams,Marlene A. Jacobson,Cyrille Sur,Gene G. Kinney,D. J. PETTIBONE,Philip R. Tiller,Sheri Smith,George D. Hartman,Craig W. Lindsley,S. E. Wolkenberg	16
10	Synthesis and SAR of GlyT1 inhibitors derived from a series of N-((4-(morpholine-4-carbonyl)-1-(propylsulfonyl)piperidin-4-yl)methyl)benzamides 2006 ·Bioorganic & Medicinal Chemistry Letters ·Zhijian Zhao,Julie A. O’Brien,Wei Lemaire,David L. Williams,Marlene A. Jacobson,Cyrille Sur,D. J. PETTIBONE,Philip R. Tiller,Sheri Smith,George D. Hartman,S. E. Wolkenberg,Craig W. Lindsley	12
11	Challenges in the development of mGluR5 positive allosteric modulators: The discovery of CPPHA 2006 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),David D. Wisnoski,Julie A. O’Brien,Wei Lemaire,David L. Williams,Marlene A. Jacobson,(unknown),Sookhee Ha,Hervé Schaffhauser,Cyrille Sur,D. J. PETTIBONE,Mark E. Duggan,P. Jeffrey Conn,George D. Hartman,Craig W. Lindsley	58
12	A Novel Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Has in Vivo Activity and Antipsychotic-Like Effects in Rat Behavioral Models 2005 ·Journal of Pharmacology and Experimental Therapeutics ·Gene G. Kinney,Julie A. O’Brien,Wei Lemaire,Maryann Burno,(unknown),Michelle K. Clements,Tsing‐Bau Chen,David D. Wisnoski,Craig W. Lindsley,Philip R. Tiller,Sheri Smith,Marlene A. Jacobson,Cyrille Sur,Mark E. Duggan,Douglas J. Pettibone,P. Jeffrey Conn,David L. Williams	229
13	A Novel Selective Allosteric Modulator Potentiates the Activity of Native Metabotropic Glutamate Receptor Subtype 5 in Rat Forebrain 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Julie A. O’Brien,Wei Lemaire,Marion Wittmann,Marlene A. Jacobson,Sookhee Ha,David D. Wisnoski,Craig W. Lindsley,Hervé Schaffhauser,Blake A. Rowe,Cyrille Sur,Mark E. Duggan,Douglas J. Pettibone,P. Jeffrey Conn,David L. Williams	132
14	A Family of Highly Selective Allosteric Modulators of the Metabotropic Glutamate Receptor Subtype 5 2003 ·Molecular Pharmacology ·Julie A. O’Brien,Wei Lemaire,Tsing‐Bau Chen,Raymond S.L. Chang,Marlene A. Jacobson,Sookhee Ha,Craig W. Lindsley,Hervé Schaffhauser,Cyrille Sur,Douglas J. Pettibone,P. Jeffrey Conn,David L. Williams	170
15	Modulation of Inhibitory Transmission in the Rat Globus Pallidus by Activation of mGluR4 2003 ·Annals of the New York Academy of Sciences ·Michael J. Marino,Ornella Valenti,Julie A. O’Brien,David R. Williams,P. Jeffrey Conn	16
16	Difference in mGluR5 Interaction between Positive Allosteric Modulators from Two Structural Classes 2003 ·Annals of the New York Academy of Sciences ·David L. Williams,Julie A. O’Brien,Wei Lemaire,Tsing‐Bau Chen,Raymond S.L. Chang,Marlene A. Jacobson,Sookhee Ha,David D. Wisnoski,Craig W. Lindsley,Cyrille Sur,Mark E. Duggan,Douglas J. Pettibone,P. Jeffrey Conn	2
17	A nonpeptide oxytocin receptor antagonist radioligand highly selective for human receptors 2002 ·European Journal of Pharmacology ·Wei Lemaire,Julie A. O’Brien,Maryann Burno,Ashok Chaudhary,Dennis Dean,Peter D. Williams,Roger Freidinger,Douglas J. Pettibone,David L. Williams	13
18	Pharmacology of L-744,453, a novel nonpeptidyl endothelin antagonist 1996 ·Life Sciences ·David L. Williams,(unknown),(unknown),Julie A. O’Brien,Edward V. Lis,Douglas J. Pettibone,Bradley V. Clineschmidt,Stephen M. Krause,Daniel F. Veber,Elizabeth M. Naylor,Prasun K. Chakravarty,Thomas F. Walsh,(unknown),(unknown),Scott W. Bagley,(unknown),William J. Greenlee	6
19	Characterization of the human oxytocin receptor stably expressed in 293 human embryonic kidney cells 1995 ·Life Sciences ·Jeffrey R. Jasper,C. Meacham Harrell,Julie A. O’Brien,Douglas J. Pettibone	38
20	Synthesis and evaluation of 2-pyridinone derivatives as HIV-1 specific reverse transcriptase inhibitors. 1. Phthalimidoalkyl and -alkylamino analogs 1992 ·Journal of Medicinal Chemistry ·J. M. HOFFMAN,John Wai,(unknown),Rhonda B. Levin,Julie A. O’Brien,Mark E. Goldman	44

About Julie A. O’Brien

Julie A. O’Brien is a scholar working on Cellular and Molecular Neuroscience, Toxicology and Endocrine and Autonomic Systems, having authored 30 papers that have together received 1.3k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (16 papers), Receptor Mechanisms and Signaling (14 papers) and Amino Acid Enzymes and Metabolism (3 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (971 citations), Biological Psychiatry (41 citations) and Toxicology (45 citations). Julie A. O’Brien has collaborated with scholars based in United States, United Kingdom and Poland. Frequent co-authors include David L. Williams, P. Jeffrey Conn, Cyrille Sur, Marlene A. Jacobson, Wei Lemaire, Craig W. Lindsley, Douglas J. Pettibone, Gene G. Kinney, David D. Wisnoski and Mark E. Duggan. Their work appears in journals such as Proceedings of the National Academy of Sciences, Annals of the New York Academy of Sciences and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact